Singapore markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.4100+0.0100 (+0.23%)
At close: 04:00PM EDT
4.4300 +0.02 (+0.45%)
After hours: 06:53PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,754
3,208
5,408
2,124
6,469
Selling general and administrative
5,669
11,213
7,605
5,580
5,364
Total operating expenses
10,424
14,421
13,013
7,704
11,833
Operating income or loss
-10,424
-14,421
-13,013
-7,704
-11,833
Interest expense
582.537
-
427.542
821.366
516.45
Total other income/expenses net
-408.4
-93,333
-607.001
441.581
-333.658
Income before tax
-11,414
-107,754
-14,048
-8,084
-12,683
Income tax expense
-8,409
-9,456
0
0
-
Income from continuing operations
-11,414
-98,298
-14,048
-8,084
-12,683
Net income
-11,414
-98,298
-14,048
-8,084
-12,683
Net income available to common shareholders
-21,430
-106,246
-24,063
-8,084
-12,683
Basic EPS
-78.43
-1.09k
-346.10
-139.88
-183.27
Diluted EPS
-78.43
-1.09k
-346.10
-139.88
-183.27
Basic average shares
1,243
97.503
69.205
57.792
69.205
Diluted average shares
1,243
97.503
69.205
57.792
69.205